# Magnitude of malnutrition and its associated factors among pediatric cancer patients on chemotherapy at oncology centers in Addis Ababa, Ethiopia, 2024

**Authors:** Habtamu Wondmagegn Atlaw, Edlework Wondmagegn Atlaw, Biniyam Demisse Andarge, Sayih Mehari Degualem, Tsegazeab Ayele Meshesha, Maycas Gembe, Habtamu Esubalew Bezie, Syeda Humaida Hasan, Syeda Humaida Hasan, Kahsu Gebrekidan, Kahsu Gebrekidan

PMC · DOI: 10.1371/journal.pone.0342544 · PLOS One · 2026-02-18

## TL;DR

This study found that nearly 28% of pediatric cancer patients in Ethiopia are malnourished, with risk factors including age, low income, and cancer type.

## Contribution

The study identifies specific risk factors for malnutrition among pediatric cancer patients in Ethiopia using a cross-sectional design.

## Key findings

- 28.4% of pediatric cancer patients undergoing chemotherapy were malnourished.
- Children aged 11–15 years and those from low-income households were most at risk for malnutrition.

## Abstract

Malnutrition among children and adolescents with cancer in low- and middle income countries significantly contributes to several adverse outcomes which have an impact on health-related quality of life and overall survival. This study aimed to assess the magnitude of malnutrition and its associated factors among pediatric cancer patients on chemotherapy.

A health institution-based cross-sectional study was conducted among pediatric cancer patients receiving chemotherapy aged from birth to 15 years attending at Black Lion specialized hospital and Saint Paul’s millennium medical college from May 1 to July 1, 2024. By using a simple random sampling method, 345 participants were selected for face to face interview and anthropometric assessments. Pre-tested semi-structured questionnaire, chart review and anthropometric measurement were used. Variables with p-value <0.25 in the bi-variable logistic regression analysis were entered and checked for association in a multivariable logistic regression model. The level of statistical significance was declared at the p-value < 0.05.

In this study, we successfully enrolled 320 pediatric cancer patients, which represents a response rate of 92.8% (320/345). The magnitude of malnutrition, defined by low BMI-for-age or weight-for-height/length z-scores, was 28.4% (91/320) (95% CI: 24.8%−31.3%). Additionally, the prevalence of stunting, based on height-for-age, was 30.6% (98/320) (95% CI: 26.5%–34.2%).Children in the age category of 11–15 years (AOR = 2.54, 95% CI; 1.18–5.48), Children’s of mothers educational level illiterate, (AOR = 2.20, 95%CI; 1.01–4.75), Children form Households which earn <2000 ETB (AOR = 2.93, 95%CI; 1.14–7.53), Children with a cancer duration of 2–4 years (AOR = 1.34, 95%CI; 1.05–1.71), Children with hematologic malignancy (AOR = 2.18, 95%CI; 1.16–3.81), Children who had co-morbidities (AOR = 1.54, 95% CI; 1.12–2.10) and, Children’s who have difficulty of swallowing (AOR = 2.11, 95%CI; 1.22–3.95) were significantly associated factors with being malnourished.

This study identified malnutrition in 28.4% (91/320) of participants undergoing chemotherapy. Children most at risk were those between 11 and 15 years old, from low-income households, with mothers who had no formal education, Children with a cancer duration of 2–4 years, with hematologic malignancies, with co-morbidities, and with difficulty swallowing.

## Linked entities

- **Diseases:** cancer (MONDO:0004992), hematologic malignancy (MONDO:0002334)

## Full-text entities

- **Genes:** EDNRB (endothelin receptor type B) [NCBI Gene 1910] {aka ABCDS, ET-B, ET-BR, ETB, ETB1, ETBR}
- **Diseases:** cognitively impaired (MESH:D003072), fungal infections (MESH:D009181), HIV (MESH:D015658), tuberculosis (MESH:D014376), loss of appetite (MESH:D001068), oral candidiasis (MESH:D002180), underweight (MESH:D013851), mucositis (MESH:D052016), depression (MESH:D003866), weight loss (MESH:D015431), Toxicities (MESH:D064420), congenital heart disease (MESH:D006330), infections (MESH:D007239), TRTs (MESH:D016609), chronic kidney failure (MESH:D007676), Malnutrition (MESH:D044342), micronutrient deficiencies (MESH:D007153), deaths (MESH:D003643), difficulty of swallowing (MESH:D003680), nutritional deficit (MESH:D009748), and vomiting (MESH:D014839), difficulty of chewing (MESH:D051346), AML (MESH:D015470), hematologic malignancies (MESH:D019337), BL (MESH:D002051), wasting (MESH:D019282), overweight (MESH:D050177), diarrhea (MESH:D003967), nausea (MESH:D009325), alopecia (MESH:D000505), acute and chronic malnutrition (MESH:D000067011), chronic renal disease (MESH:D051436), anorexia (MESH:D000855), Cancer (MESH:D009369), altered taste (MESH:D004408), Stunting (MESH:D006130), sarcopenia (MESH:D055948), bowel obstructions (MESH:D012778), HL (MESH:C538324), Comorbidity (MESH:D004194)
- **Chemicals:** PONE-D (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915981/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915981/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915981/full.md

---
Source: https://tomesphere.com/paper/PMC12915981